Showing results (271-280 of 471) with videos related to

Sort By:
Pageof 48
Current Opinion in Pharmacology|January 29, 2003
CB2 cannabinoid receptor agonists: pain relief without psychoactive effects?T Philip Malan, Mohab M Ibrahim, Josephine Lai, et al.
Urology|December 15, 2004
Efficiency and cost of treating proximal ureteral stones: shock wave lithotripsy versus ureteroscopy plus holmium:yttrium-aluminum-garnet laserBrian D Parker, Robert W Frederick, T Philip Reilly, et al.
Bone Marrow Transplantation|March 5, 1998
High-dose chemotherapy with hematopoietic stem cell transplantation in patients with mantle cell or diffuse centrocytic non-Hodgkin's lymphomas: a single center experience on 18 patientsJ Y Blay, C Sebban, C Surbiguet, et al.
Journal De Genetique Humaine|March 1, 1983
[Prometaphase cytogenetic study of 13 cases of Wilms' tumor without aniridia]M De Blois, T Philip, G M Lenoir, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|August 4, 2001
[Immunization for children treated for solid tumors: what are the guidelines?]P Marec-Bérard, D Floret, M Schell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1994
Autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma and CNS involvement: those transplanted with active CNS disease have a poor outcome--a report by the European Bone Marrow Transplant Lymphoma RegistryC D Williams, R Pearce, G Taghipour, et al.
Bulletin Du Cancer|September 24, 2004
Can MIBG scan replace the need for bone marrow assessment at diagnosis and reassessment in stage 4 neuroblastomas?D Frappaz, V Combaret, C Desuzinges, et al.
International Journal of Cancer|December 15, 1986
EBV-negative and -positive Burkitt cell lines variably express receptors for B-cell activation and differentiationM C Favrot, O Maritaz, T Suzuki, et al.
Bulletin Du Cancer|July 27, 1999
[Epidemiology of non-Hodgkin's lymphoma: recent data]C Chassagne-Clément, J Y Blay, I Treilleux, et al.
Blood|October 15, 1995
The C5R protocol: a regimen of high-dose chemotherapy and radiotherapy in primary cerebral non-Hodgkin's lymphoma of patients with no known cause of immunosuppressionJ Y Blay, D Bouhour, C Carrie, et al.
Pageof 48